Results 71 to 80 of about 14,200 (285)

Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial

Journal of Clinical Medicine, 2021
Background and Aims: Ulcerative colitis (UC) is a chronic inflammatory disease. Fecal microbial transplantation (FMT) is a promising alternative treatment.
J. Březina, L. Bajer, P. Wohl, D. Ďuricová, P. Hrabák, A. Novotný, J. Koželuhová, M. Lukáš, J. Mrázek, K. Fliegerová, S. Kvasnová, Mekadim Chahrazed, J. Mareš, J. Spicak, P. Drastich   +14 more
semanticscholar   +1 more source

Impact of timing on mucosal healing during restaging endoscopy in pediatric Crohn's disease: A retrospective cohort study

JPGN Reports, EarlyView.
Abstract While endoscopic remission is an important target in pediatric Crohn's disease (CD), no consensus for restaging timing exists. This retrospective cohort study assessed the timing and impact of restaging endoscopy in children with new CD in remission, comparing earlier ( ≤ 9 months) versus later endoscopy.
Anna Janecek, Alexandra S. Hudson, David L. Suskind, Hengqi B. Zheng, Samuel Simpson, Dale Lee, Ghassan Wahbeh, Hannibal Person   +7 more
wiley   +1 more source

The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial.

PLoS ONE, 2014
UnlabelledThe anti-inflammatory agent, mesalamine (5-aminosalicylic acid) has been shown to decrease mucosal inflammation in ulcerative colitis. The effect of mesalamine in HIV-infected individuals, who exhibit abnormal mucosal immune activation and ...
Ma Somsouk, Richard M Dunham, Michelle Cohen, Rebecca Albright, Mohamed Abdel-Mohsen, Teri Liegler, Jeffrey Lifson, Michael Piatak, Robert Gorelick, Yong Huang, Yuaner Wu, Priscilla Y Hsue, Jeffrey N Martin, Steven G Deeks, Joseph M McCune, Peter W Hunt   +15 more
doaj   +1 more source

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection [PDF]

, 2018
L
Altorjay, István, Blank, Marion, Chevrier, Marc, Cornillie, Freddy J., Danese, Silvio, Feagan, Brian, Gionchetti, Paolo, Hanauer, Stephen B., Johanns, Jewel, Lukas, Milan, Plevy, Scott, Popp, John, Regueiro, Miguel, Reinisch, Walter, Rutgeerts, Paul, Sandborn, William J., Sorrentino, Dario, Zou, Bin   +17 more
core   +1 more source

The Impact of Disease Activity and Medications on Pregnancy and Fetal Outcomes in Women With Inflammatory Bowel Disease: A Cohort Study From the IBD‐ME Group

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Women with inflammatory bowel disease (IBD) and their children are at higher risk of adverse outcomes. The primary aim was to examine the association between IBD and adverse pregnancy outcomes. The secondary aim was to assess the impact of maternal IBD and medications used on children's outcomes.
Mahmoud Mosli, Nahla Azzam, Majid Almadi, Heba Alfarhan, Mansour Altuwaijiri, Abdulrahman Aljebreen, Othman Alharbi, Mohammed Abaalkhail, Maryam Jaran, Abdulaziz Altamimi, Nouf Al Turki, Lubna Alharbi, Joud A. L. Ghamdi, Amal Al Dakhil   +13 more
wiley   +1 more source

Efficacy and Tolerance of 5-Aminosalicylic Acid Suppositories in the Treatment of Ulcerative Proctitis: A Review of Two Double-Blind, Placebo Controlled Trials

Canadian Journal of Gastroenterology, 1990
The efficacy and tolerance of 500 mg 5-aminosalicylic acid (mesalamine) suppositories in the treatment of ulcerative proctitis were assessed in two double-blind, placebo controlled studies of six weeks' duration, involving a total of 173 patients.
CN Williams
doaj   +1 more source

Differential diagnosis problem of pulmonary changes in ulcerative colitis [PDF]

Vojnosanitetski Pregled, 2010
Introduction. Inflammatory intestinal diseases are often accompanied with extraintestinal and even pulmonary manifestations. The treatment of these intestinal diseases includes sulphasalazine and mesalazine, which may have undesirable allergic and other ...
Đurić Mirna, Považan Đorđe, Sečen Svetozar, Jović Jelena   +3 more
doaj   +1 more source

Clinical and pathologic remission of pediatric ulcerative colitis with serum-derived bovine immunoglobulin added to the standard treatment regimen [PDF]

, 2017
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that is particularly troublesome for pediatric patients, as current therapeutic options consist of biologic agents and steroids which alter the immune response and have the harmful side ...
Ramos-Soriano, Asuncion G., Soriano, Rachelle A.   +1 more
core   +2 more sources

Vedolizumab Induces Remission in Two Cases of Ulcerative Colitis With Upper Gastrointestinal Involvement

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Ulcerative colitis (UC) predominantly affects the colon; upper gastrointestinal involvement (UGI) has been reported, but no established treatments exist. We report two cases of UC with concomitant UGI that showed positive responses to vedolizumab therapy.
Shinya Nakatani, Yuta Yamazaki, Kensuke Higuchi, Yumi Otoyama, Norihiro Suzuki, Kazuo Kikuchi, Takahisa Fujiwara, Atsushi Katagiri, Jyun Ohara, Hitoshi Yoshida   +9 more
wiley   +1 more source

Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers

Clinical Pharmacology: Advances and Applications, 2019
Abhijeet Jakate,1 Brian McNamee,2 Donald Burkindine31Clinical Pharmacology, Allergan plc, Madison, NJ, USA; 2Clinical Pharmacology, Allergan Biologics Ltd, Liverpool, UK; 3QPS Bio-Kinetic, Springfield, MO, USAObjective: Delayed-release mesalamine 400 mg ...
Jakate A, McNamee B, Burkindine D
doaj